Home › Funds › Euclidean Capital LLC › ALEC

Euclidean Capital LLC position in ALEC

ALECTOR INC COM · Health Care

Euclidean Capital LLC reported holding 1,307,858 shares of ALEC (ALECTOR INC COM) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 0.60% of its reported portfolio and ranking #8 among its reported holdings. Euclidean Capital LLC has disclosed ALEC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.31M sh
Reported value held$2.63M
Portfolio Weight0.60%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Euclidean Capital LLC's ALEC position evolved

Euclidean Capital LLC first disclosed a stake in ALEC in Q3 2023 at 1,307,858 shares (US$8.5M). The position peaked in Q4 2023 at 1,307,858 shares, worth US$10.4M. Across 12 filings, Euclidean Capital LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,307,858 shares valued at US$2.6M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.31M $8.47M New
Q4 2023 1.31M $10.44M Hold
Q1 2024 1.31M $7.87M Hold
Q2 2024 1.31M $5.94M Hold
Q3 2024 1.31M $6.09M Hold
Q4 2024 1.31M $2.47M Hold
Q1 2025 1.31M $1.61M Hold
Q2 2025 1.31M $1.83M Hold
Q3 2025 1.31M $3.87M Hold
Q4 2025 1.31M $2.04M Hold
Q1 2026 1.31M $2.81M Hold
Q2 2026 1.31M $2.63M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALEC and 13F data

ALEC (ALECTOR INC COM) is a Health Care company. 30 other funds we track also report a position in ALEC — the largest reported positions include TCG Crossover Management, LLC (US$20.1M), Kynam Capital Management, LP (US$7.7M), Merck & Co., Inc. (US$7.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALEC

All ALEC fund holders →

FAQ

How long has Euclidean Capital LLC held ALEC?

Euclidean Capital LLC has disclosed ALEC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Euclidean Capital LLC's current position in ALEC?

As of Q2 2026, Euclidean Capital LLC holds 1.31M shares of ALEC (ALECTOR INC COM), valued at $2.63M, representing 0.60% of its reported portfolio and ranking #8.

Has Euclidean Capital LLC been buying or selling ALEC?

In the latest 13F filing (Q2 2026), Euclidean Capital LLC held unchanged its position in ALEC. The position peaked in Q4 2023 at 1.31M shares.

Which other funds hold ALEC?

Other major institutional holders of ALEC include TCG Crossover Management, LLC, Kynam Capital Management, LP, Merck & Co., Inc., among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.